» Articles » PMID: 10791998

Epidermal Growth Factor Receptor Expression in Neurofibromatosis Type 1-related Tumors and NF1 Animal Models

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2000 May 3
PMID 10791998
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

We have found that EGF-R expression is associated with the development of the Schwann cell-derived tumors characteristic of neurofibromatosis type 1 (NF1) and in animal models of this disease. This is surprising, because Schwann cells normally lack EGF-R and respond to ligands other than EGF. Nevertheless, immunoblotting, Northern analysis, and immunohistochemistry revealed that each of 3 malignant peripheral nerve sheath tumor (MPNST) cell lines from NF1 patients expressed the EGF-R, as did 7 of 7 other primary MPNSTs, a non-NF1 MPNST cell line, and the S100(+) cells from each of 9 benign neurofibromas. Furthermore, transformed derivatives of Schwann cells from NF1(-/-) mouse embryos also expressed the EGF-R. All of the cells or cell lines expressing EGF-R responded to EGF by activation of downstream signaling pathways. Thus, EGF-R expression may play an important role in NF1 tumorigenesis and Schwann cell transformation. Consistent with this hypothesis, growth of NF1 MPNST lines and the transformed NF1(-/-) mouse embryo Schwann cells was greatly stimulated by EGF in vitro and could be blocked by agents that antagonize EGF-R function.

Citing Articles

Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.

Tang N, Cheng L, Hao J, Xu B, Pan X, Wei X Acta Neuropathol Commun. 2025; 13(1):45.

PMID: 40025578 PMC: 11871713. DOI: 10.1186/s40478-025-01965-6.


Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.

Paudel S, Hutzen B, Miller K, Garfinkle E, Chen C, Wang P Front Immunol. 2024; 15:1384623.

PMID: 39044819 PMC: 11263800. DOI: 10.3389/fimmu.2024.1384623.


The therapeutic potential of neurofibromin signaling pathways and binding partners.

Baez-Flores J, Rodriguez-Martin M, Lacal J Commun Biol. 2023; 6(1):436.

PMID: 37081086 PMC: 10119308. DOI: 10.1038/s42003-023-04815-0.


Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment.

Kershner L, Choi K, Wu J, Zhang X, Perrino M, Salomonis N JCI Insight. 2022; 7(18.

PMID: 36134665 PMC: 9675562. DOI: 10.1172/jci.insight.154513.


Malignant peripheral nerve sheath tumor: models, biology, and translation.

Somatilaka B, Sadek A, McKay R, Le L Oncogene. 2022; 41(17):2405-2421.

PMID: 35393544 PMC: 9035132. DOI: 10.1038/s41388-022-02290-1.


References
1.
Cichowski K, Shih T, Schmitt E, Santiago S, Reilly K, McLaughlin M . Mouse models of tumor development in neurofibromatosis type 1. Science. 1999; 286(5447):2172-6. DOI: 10.1126/science.286.5447.2172. View

2.
DeClue J, Papageorge A, Fletcher J, Diehl S, Ratner N, Vass W . Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell. 1992; 69(2):265-73. DOI: 10.1016/0092-8674(92)90407-4. View

3.
Pinkas-Kramarski R, Alroy I, Yarden Y . ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling. J Mammary Gland Biol Neoplasia. 1997; 2(2):97-107. DOI: 10.1023/a:1026343528967. View

4.
Pfeiffer S, WECHSLER W . Biochemically differentiated neoplastic clone of Schwann cells. Proc Natl Acad Sci U S A. 1972; 69(10):2885-9. PMC: 389667. DOI: 10.1073/pnas.69.10.2885. View

5.
Stefansson K, Wollmann R, Jerkovic M . S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes. Am J Pathol. 1982; 106(2):261-8. PMC: 1916175. View